Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-16

Clinical Trial Update: Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery [Phase 2, Phase 3]

View source ↗

Summary

The document reports a Phase 2/Phase 3 clinical trial evaluating erythropoietin for protecting kidney function after cardiac surgery. The study has completed, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythropoietin (erythropoietin)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Kidney Failure, Acute | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2009-06-16